共查询到20条相似文献，搜索用时 31 毫秒
1.
为选育毒害艾美耳球虫(E.necatri)早熟株,了解其繁殖力,为早熟弱毒活苗的研制奠定基础,本试验运用球虫的单卵囊分离技术得到一株E.necatrix(P0),并对其进行了早熟选育,得到了E.necatrix早熟株P8。P0和P8分别以0.05×104、0.1×104、0.5×104和1×104个/只的剂量接种11日龄雏鸡,接种后第7～13天每天检测粪便中的卵囊产量。结果表明,P0与P8均为接种0.5×104个/只的卵囊产量最大;P8的繁殖力是P0的55%;P8的卵囊高峰期较P0有提前趋势。 相似文献
2.
Fifty years of anticoccidial vaccines for poultry (1952-2002) 总被引：6，自引：0，他引：6
Williams RB 《Avian diseases》2002,46(4):775-802
Although earlier investigators experimented with anticoccidial vaccines, the world's first commercially successful product was developed by Prof S. A. Edgar of Auburn University, Auburn, AL. This product contained live, nonattenuated Eimeria tenella oocysts and was first marketed by Dorn and Mitchell, Inc., in 1952. Under the trade names of DM Cecal Coccidiosis Vaccine, Coxine, NObiCOX, and CocciVac, it went through several formulations containing various Eimeria species that parasitize chickens, and a further product containing turkey Eimeria species was also developed. After many product and company changes, one turkey and two chicken formulations of CocciVac are still marketed worldwide by Schering-Plough Animal Health, Inc. Chicken and turkey formulations of Immucox, a similar type of vaccine, were developed by Dr. E.-H. Lee and first marketed in 1985 in Canada by Vetech Laboratories, Inc. In 1974, Dr. T. K. Jeffers of Hess and Clark, Inc., Ashland, OH, published his discovery of precocious lines of coccidia, which facilitated the development of the first attenuated anticoccidial vaccine. For commercial reasons, Jeffers was unable to do this himself, but this first attenuated vaccine was designed by Dr. M. W. Shirley and colleagues at the Houghton Poultry Research Station (HPRS) in the United Kingdom. The vaccine was commercially developed under license in the United Kingdom by Glaxo Animal Health Ltd. and then Pitman-Moore, Inc., and launched in The Netherlands during 1989 under the trade name Paracox. After further changes in company ownership, two formulations for chickens are now marketed worldwide by Schering-Plough Animal Health, Inc. Attenuation of coccidia by embryo adaptation was reported in 1972 in the United Kingdom by Dr. P. L. Long, who originally worked at the HPRS and later became a professor at the University of Georgia, Athens, GA. An embryo-adapted line of E. tenella was included with precocious lines of other species in a series of three attenuated vaccines for chickens under the trade name Livacox, developed by Dr. P. Bedrník and launched in the Czech Republic in 1992 by Biopharm. The formulations of all other commercially available live anticoccidial vaccines for poultry are currently based upon the scientific principles established for the CocciVac, Paracox or Livacox vaccines. 相似文献
3.
Jorgensen WK Anderson GR Jeston PJ Blight GW Molloy JB 《Australian veterinary journal》2006,84(3):89-94
OBJECTIVE: To attenuate two strains of Eimeria tenella by selecting for precocious development and evaluate the strains in characterisation trials and by field evaluation, to choose one precocious line for incorporation into an Australian live coccidiosis vaccine for poultry. DESIGN: Two strains from non-commercial flocks were passaged through chickens while selecting for precocious development. Each strain was characterised for drug sensitivity, pathogenicity, protection against homologous and heterologous challenge, and oocyst output in replicated experiments in which the experimental unit was a cage of three birds. Oocyst output and/or body weight gain data collected over a 10 to 12 day period following final inoculation were measured. Feed conversion ratios were also calculated where possible. RESULTS: Fifteen passages resulted in prepatent periods reduced by 24 h for the Redlands strain (from 144 h to 120 h) and 23 h for the Darryl strain (from 139 h to 116 h). Characterisation trials demonstrated that each precocious line was significantly less pathogenic than its parent strain and each effectively induced immunity that protected chickens against challenge with both the parent strain and other virulent field strains. Both lines had oocyst outputs that, although significantly reduced relative to the parent strains, remained sufficiently high for commercial vaccine production, and both showed susceptibility to coccidiostats. CONCLUSION: Two attenuated lines have been produced that exhibit the appropriate characteristics for use in an Australian live coccidiosis vaccine. 相似文献
4.
Two federally licensed attenuated live transmissible gastroenteritis (TGE) virus vaccines (an IM vaccine and an oral-IM vaccine) and 1 nonlicensed nonattenuated live TGE virus vaccine were evaluated and compared in sows free of TGE virus-neutralizing antibodies. Litters from the sows were challenge exposed at 3 and 5 days of age, and results were combined according to the vaccine administered to the sows. The survivability of pigs suckling sows vaccinated with the nonattenuated vaccine was significantly (P less than 0.01) greater than that of pigs suckling sows vaccinated with the IM attenuated vaccine, significantly (P less than 0.05) greater than that of pigs suckling sows vaccinated with the oral-IM attenuated vaccine, and significantly (P less than 0.05) greater than that of pigs suckling sows that had not been vaccinated. The differences, however, between survivability of litters from sows vaccinated with the IM attenuated vaccine or the oral-IM attenuated vaccine and that of litters from the sows not vaccinated were not significant (P greater than 0.10). The nonattenuated TGE vaccine, although giving a higher level of protection than the attenuated vaccine, was eventually overwhelmed. Dexamethasone did not increase the incidence of diarrhea, and levamisole did not potentiate the lactogenic immunity in sows after given their first dose of the nonattenuated vaccine. Survivability in litters suckling sows that developed diarrhea after given their first dose of the nonattenuated vaccine was not greater than that in litters suckling sows that did not develop diarrhea. The best results were obtained when 3-day-old suckling pigs were challenge exposed with virulent TGE virus. 相似文献
5.
《The Journal of Applied Poultry Research》2018,27(1):38-44
Coccidiosis control for breeding and laying chickens requires the development of immunity against multiple Eimeria species. Only one vaccine was widely available to producers in the European Union (EU) from 1991 until 2015. Recently, 2 new products have been introduced to the market. The 3 vaccines were compared with respect to the onset of immunity in pen studies, where sample birds were challenged at 21, 25, 28, and 32 d of age to determine the time at which lesion scores became significantly different from unvaccinated controls, the “onset of immunity.” The vaccines were given by oral gavage to eliminate any effect of application methodology on the onset of immunity. “Complete Immunity,” defined as no coccidiosis lesions following challenge, was only achieved for one species (Eimeria tenella) by one vaccine through the final challenge at 32 d. Immunity remained incomplete for all other challenge groups for the duration of the experiment. Onset of immunity was detected by 25 d of age in only one vaccine group for all 5 challenge species tested (E. acervulina, E. maxima, E. tenella, E. necatrix, E. brunetti); and while onset of immunity was detected for some species with the other vaccines by 21 to 32 d of age, neither of the other 2 vaccines demonstrated onset of immunity to all 5 challenge species by the end of the experiment. Delayed onset of immunity could adversely affect pullet weight with early field challenge, as indicated by bird weights taken before and after challenge. 相似文献
6.
Precocious lines of Eimeria acervulina "Cu" and "I" strains were obtained after 25 passages of oocysts in chickens that showed a shortening of the prepatent period for first oocyst output from 96 h to 81 and 82 h, respectively. Both precocious lines were evaluated for pathogenicity using as criteria weight gain, lesion score and total oocyst production. Infection of the "Cu" precocious line in chickens showed a high weight gain, low lesion score and low oocyst production, when compared to parent strain infected chickens. However, the results did not show a significant difference in relation to the criteria used above for the E. acervulina "I" precocious line when compared to its parent strain. This suggests a low degree of attenuation for the "I" strain but good attenuation for the precocious "Cu" line. The histopathological observations of chickens infected with the E. acervulina "Cu" parent strain and precocious line, comparing life cycle and intestinal lesions, showed: (1) parasite stages only in the border cells of infected chicken intestinal villi, for the precocious line; (2) parasite stages in the border cells of the intestinal villi and submucosa cells near the Lieberkühn glands of the intestine; and (3) high degree of inflammatory cells around the parasites in chickens infected with the parent strain. The "Cu" strain was also characterized for sensitivity against eight anticoccidial drugs. Sensitivity was observed for four anticoccidial drugs and partial resistance for four other drugs, although the strain had never had previous contact with anticoccidial drugs, suggesting the presence of a natural resistance factor. This Brazilian E. acervulina "Cu" precocious line showed attenuation for pathogenicity in chickens, suggesting that it could be a suitable strain for use as a live vaccine in Brazil. 相似文献
7.
为了确定柔嫩艾美耳球虫（Eimenatenella）早熟株合适的免疫剂量,本文设立7个早熟株免疫攻虫组、1个不免疫攻虫组和1个不免疫不攻虫组,免疫组的免疫剂量为孢子化卵囊100、200、400、600、800、1000和2000个／羽,经嗉囊感染,7日龄首次免疫,14日龄以同等剂量进行第二次免疫,21日龄以8×10^4个／羽的同源母株进行攻虫,28日龄结束试验,以存活率、增重、肠道病变记分、血便数量、卵囊减少率为观测指标。对免疫保护效果较好的3个免疫剂量进行重复试验,同时设置商品化球虫疫苗对照组,免疫方法、试验周期、试验指标同第一批试验。结果显示：攻虫后,不免疫攻虫组出现5％死亡,而各免疫组来出现死亡;各免疫组卵囊减少率在61．57％～69．52％;200～2000免疫组的增重与不免疫不攻虫组差异不具备显著统计学意义（P〉0．05）;600～2000免疫组的肠道病变记分和血便数量均明显少于不免疫攻虫组（P〈0．05）。用600、800和1000进行重复试验,三个免疫组攻虫期间均来出现死亡,而不免疫组和疫苗对照组均出现5％死亡;三个免疫组的增重均明显高于不免疫攻虫组和疫苗对照组（P〈0．05）;早熟株免疫组的肠道病变记分和血便数量明显低于不免疫攻虫组（P〈0．05）,而疫苗对照组与不免疫攻虫组的相当（P〉0．05）;卵囊减少率在66.30％-78．75％,高于疫苗对照组的51．82％。结果表明,该柔嫩艾美耳球虫早熟株保持了良好的免疫原性,不同免疫剂量均能诱发鸡产生免疫保护力,其中600、800和1000个／羽的免疫效果均优于疫苗对照组,可考虑以600个／羽作为该早熟株在疫苗制备中的推荐免疫剂量。 相似文献
8.
We studied the antibody responses to transmissible gastroenteritis (TGE) in serum, colostrum, and milk from sows vaccinated with 2 attenuated (1 IM and 1 oral-IM) and 1 nonattenuated live vaccines and the relationship of these responses with the survivability of the sow's suckling pigs after challenge exposure with virulent TGE virus. Contrary to previous studies, the anti-TGE virus-neutralizing geometric mean titers (GMT) in the milk of sows vaccinated with attenuated vaccines at 3 and 5 days of lactation were similar to that found in the colostrum. Colostral and serum antibody titers were highest in sows given 2 injections of the IM attenuated vaccine. Half of the sows given the oral-IM attenuated vaccine did not seroconvert after 2 oral doses. Only sows vaccinated with the nonattenuated live vaccine had milk GMT that remained high for 21 days after farrowing. The linear relationship between colostral GMT and percentage of survivability of suckling pigs challenge exposed at 3 days of age was significant (P less than 0.05), although the relationship between serum GMT and percentage of survivability and the relationship between milk GMT and percentage of survivability were not significant (P greater than 0.10). The linear relationship between colostral (P less than 0.10) or pre-challenge exposure milk (P less than 0.05) GMT and percentage of survivability of suckling pigs challenge exposed at 5 days of age was significant.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献
9.
鸡和缓艾美耳球虫早熟虫株选育及其生物学特性研究 《畜牧与饲料科学》2016,37(9):15-15
按照Jeffers1975年建立的艾美耳属球虫早熟虫株选育方法,对鸡和缓艾美耳球虫巴彦淖尔株（SY-MB株）进行了单卵囊分离、扩增和早熟虫株的选育。经SPF鸡15代传代之后,分离株的潜隐期由96 h缩短至77 h,缩短了19 h。按索勋等1998年建立的方法对选育出的和缓艾美耳球虫巴彦淖尔早熟株（SY-mb77株）进行10代非选择性传代,证明该早熟虫株的潜隐期、卵囊产量、免疫原性和致病性均具备早熟虫株特性,并能有效抵抗强毒虫株的攻击。 相似文献
10.
Bivalent Newcastle disease (ND)/infectious bursal disease (IBD) and trivalent ND/IBD/infectious bronchitis (IB) inactivated oil emulsion vaccines were prepared in the laboratory and evaluated under field conditions. Broiler breeder parent chickens previously vaccinated with live vaccines were inoculated with commercial monovalent ND and experimental bivalent or trivalent oil emulsion vaccines. The commercial vaccine induced a higher initial ND haemagglutination inhibition (HI) response than the experimental vaccines but, by 34 weeks after vaccination, the mean ND HI levels were not significantly different in any of the three flocks. All three vaccines provided sufficient ND immunity to protect against the clinical disease and egg production losses. The IBD responses of both flocks vaccinated with oil emulsion vaccine were similar to each other and only slightly lower than those flocks vaccinated with monovalent IBD oil emulsion vaccine in earlier experiments. Six weeks after vaccination, sufficient immunity was transferred to protect all the progeny against IBD challenge up to 33 days of age and some of them up to 45 days of age. Thirty-four weeks after vaccination of the parents with oil emulsion vaccine, the progeny were totally immune up to 27 days of age and some of them were immune until 37 days. Application of oil emulsion vaccines in bivalent or trivalent form did not impair the responses of the chickens to the monovalent components. 相似文献
11.
An experiment was conducted to investigate the effects of polysaccharide extracts (E) of two mushrooms, Lentinus edodes (LenE) and Tremella fuciformis (TreE), and an herb, Astragalus membranaceus (AstE), on the immune responses of chickens infected with Eimeria tenella. A total of 180 broiler chickens were assigned to nine groups: three groups were fed with each of the extracts (LenE, TreE, and AstE), three groups were fed with the extracts and immunized with live oocyst vaccine (LenE+V, TreE+V, and AstE+V), a group was immunized with the vaccine only, and there were two controls (E. tenella-infected and noninfected groups). The oocyst vaccine was given at 4 days of age, and the extracts (1 g/kg of the diet) were supplemented from 8 to 14 days of age. At 18 days of age, all birds except those in the noninfected group were infected with 9 x 10(4) sporulated oocysts. The results showed that at 7 days postinfection (p.i.), birds fed the extracts without vaccination had lower body weight (BW) gain than those given the vaccine only. However, the extracts in conjunction with the vaccine significantly enhanced BW gain of the infected chickens compared with the vaccine group. Of the three extracts, LenE and TreE showed a better growth-promoting effect. The extracts largely increased oocyst excretion of droppings during the primary response postvaccination. The cecal peak oocyst output and lesion scores measured at 7 days p.i. were higher in the groups fed the extracts than in the group immunized with the vaccine only, whereas those of the groups fed with the extracts and immunized with the vaccine were not significantly different from the vaccine group. Of the three extracts, both LenE- and AstE-fed groups showed lower cecal oocyst output. Thus, as compared with the extracts, the live, attenuated vaccine showed better results with significantly increased immune response in coccidial infected birds. The polysaccharide extracts may prove useful against avian coccidiosis, and, particularly when they are used in conjunction with vaccine, they have shown preliminary promise against the experimental coccidial infection. 相似文献
12.
The purpose of the present study was to evaluate the species composition and salinomycin sensitivity of Eimeria oocysts isolated from commercial broiler farms that differed by means of coccidiosis control (anticoccidial drugs [ACD] vs. live oocyst vaccines [VAC]). A comparison of Eimeria species composition and salinomycin sensitivity was also made before and after a producer switched from salinomycin to live oocyst vaccines. In general, no significant difference was observed in the concentration of Eimeria spp. oocysts in litter from VAC-utilizing farms compared to litter from ACD-utilizing farms. Application of PCR-based methods to detect coccidia found that Eimeria species distribution in litter from VAC operations more closely resembled the species composition in the live oocyst vaccines. Drug sensitivity testing found that Eimeria oocysts from VAC operations displayed greater salinomycin sensitivity as measured by weight gain and feed conversion efficiency compared to oocysts from ACD farms. These findings provide additional evidence for the usefulness of live oocyst vaccines to restore ionophore sensitivity in poultry operations that contain an ionophore-resistant population of Eimeria spp. oocysts. 相似文献
13.
Infectious bronchitis (IB) is a highly contagious viral disease and is responsible for considerable economic losses in the poultry industry, worldwide. To mitigate the IB-associated losses, multiple vaccines are being applied in the sector with variable successes and thus necessitating the development of a potent vaccine to protect against the IB in the poultry. In the present study, we investigated a bivalent live attenuated vaccine consisting of IB virus (IBV) strain H120 (GI-1 lineage) and D274 (GI-12 lineage) to evaluate its protection against heterologous variant of IBV (GI-23 lineage) in chicken. Protection efficacy was evaluated based on the serology, clinical signs, survival rates, tracheal and kidney histopathology and the viral shedding. Results demonstrated that administering live H120 and D274 (named here Classivar®) vaccine in one day-old and 14 days-old provided 100 % protection. We observed a significant increase in the mean antibody titers, reduced virus shedding, and ameliorated histopathology lesions compared to routinely used vaccination regimes. These results revealed that usage of different IBV vaccines combination can successfully ameliorate the clinical outcome and pathology in vaccinated chicks especially after booster vaccination regime using Classivar®. In conclusions, our data indicate that Classivar® vaccine is safe in chicks and may serve as an effective vaccine against the threat posed by commonly circulating IBV strains in the poultry industry. 相似文献
14.
《The Journal of Applied Poultry Research》2014,23(3):523-535
Contrary to the traditional view that layer flocks housed in conventional cages are unlikely to suffer coccidiosis caused byEimeria species, this enteric disease has become an emergent issue. Coccidiosis outbreaks in layers are frequently associated with the failure to develop protective immunity at a young age. Layer hens housed in cages are usually sourced from replacement layer pullets housed in similar cages in the rearing barn. Live coccidiosis vaccines administered to young chicks provide a small dose of vaccine oocysts that infect and replicate within the vaccinated birds, resulting in the release of progeny oocysts into the rearing environment; these oocysts must become infective (i.e., sporulate) and then reinfect the partially immune birds in order for the vaccine to generate complete protective immunity. Three factors are needed for successful oocyst sporulation: temperature (4 to 37°C; optimal 29°C), oxygen access, and adequate RH. The purpose of this study was to assess the degree of protective immunity elicited by birds spray-vaccinated with a live coccidiosis vaccine at the hatchery. During the critical period for oocyst sporulation and cycling, RH levels decreased to 13 to 19%, resulting in inadequate oocyst cycling and minimal protection against homologous challenge at 6 and 12 wk of age. This vaccination failure highlights the need to monitor RH in the barn and modify the barn environment so that conditions promote, rather than impede, the success of live coccidiosis vaccines. 相似文献
15.
Philippe M?hl Florence Cliquet Anne-Laure Guiot Enel Niin Emma Fournials Nathalie Saint-Jean Michel Aubert Charles E Rupprecht Sylvie Gueguen 《Veterinary research》2014,45(1)
The SAG2 vaccine (RABIGEN® SAG2) is a modified live attenuated rabies virus vaccine, selected from the SAD Bern strain in a two-step process of amino acid mutation using neutralizing monoclonal antibodies. The strain is genetically stable and does not spread in vivo or induce a persistent infection. Its absence of residual pathogenicity was extensively demonstrated in multiple target and non target species (such as wild carnivores and rodent species), including non-human primates. The efficacy of SAG2 baits was demonstrated according to the EU requirements for the red fox and raccoon dog. The use of safe and potent rabies vaccines such as SAG2 largely contributed to the elimination of rabies in Estonia, France, Italy and Switzerland. Importantly, these countries were declared free of rabies after few years of oral vaccination campaigns with SAG2 baits distributed with an appropriate strategy. The excellent tolerance of the SAG2 vaccine has been confirmed in the field since its first use in 1993. No safety issues have been reported, and in particular no vaccine-induced rabies cases were diagnosed, after the distribution of more than 20 million SAG2 baits in Europe. 相似文献
16.
Toussaint JF Coen L Letellier C Dispas M Gillet L Vanderplasschen A Kerkhofs P 《Veterinary research》2005,36(4):529-544
Bovine herpesvirus 1 (BoHV-1) has frequently been used as a model for testing parameters affecting DNA immunisation in large animals like cattle. However, the selection of target antigens has been poorly studied, and most of the experiments have been conducted in mice. In the present study, we demonstrated in cattle that a DNA vaccine encoding BoHV-1 glycoprotein gD induces higher neutralising antibody titres than vaccines encoding BoHV-1 gC. Additionally, we show that a DNA vaccine encoding a secreted form of gD induces a higher immune response than a vaccine encoding full-length gD. However, the enhanced immunogenicity associated with the secretion of gD could not be extended to the glycoprotein gC. The current study also describes for the first time the development and the evaluation of a DNA vaccine encoding the major tegument protein VP8. This construct, which is the first BoHV-1 plasmid vaccine candidate that is not directed against a surface glycoprotein, induced a high BoHV-1 specific cellular immunity but no humoral immune response. The calves vaccinated with the constructs encoding full-length and truncated gD showed a non-significant tenfold reduction of virus excretion after challenge. Those calves also excreted virus for significantly (p < 0.05) shorter periods (1.5 days) than the non-vaccinated controls. The other constructs encoding gC and VP8 antigens induced no virological protection as compared to controls. Altogether the DNA vaccines induced weaker immunity and protection than conventional marker vaccines tested previously, confirming the difficulty to develop efficient DNA vaccines in large species. 相似文献
17.
In an attempt to investigate the immune efficacy ofa DNA prime-protein booster strategy against avian coccidiosis with a chimeric construct, the Eimeria tenella antigen gene (3-1E) and chicken interferon gamma gene (ChIFN-gamma) were subcloned into the mammalian expression vector proVAX forming the plasmids proE and prol, and then linked by splicing overlap extension by polymerase chain reaction to construct the chimeric plasmid prolE; the chimeric protein (rlE) was expressed in Escherichia coli harboring the constructed plasmid pGEX/IE. Broilers were administered two intramuscular injections with the constructed DNA vaccines (50 microg); in the protein booster groups 100 microg of the rlE were given following the proIE prime. After challenge the proIE-vaccinated chickens showed the protective immunity as demonstrated by significantly reduced oocyst shedding compared with chickens immunized with proE, but the prolE vaccine did not have an additive effect of increasing antibody titer and body weight gain. The chickens in the rlE booster groups had significantly higher specific antibody responses than those immunized with prolE, and displayed further decreased oocyst shedding and increased body weight gain. Taken together, these results indicate that ChIFN-gamma exerts an adjuvant effect coexpressed with 3-1E and provide the first evidence that the DNA prime-protein booster strategy is able to augment the protective efficacy of chimeric DNA vaccine against challenge with Eimeria tenella. 相似文献
18.
Methner U Keiling S Kreutzer B Schweinitz P 《DTW. Deutsche tier?rztliche Wochenschrift》2002,109(4):149-153
In the progeny of breeder birds which had been vaccinated with live Salmonella Typhimurium and inactivated Salmonella Enteritidis vaccines, the caecal and systemic colonisation by a live Salmonella Enteritidis and a live Salmonella Typhimurium vaccine was studied. The efficacy of the oral immunisation of chicks from vaccinated and non-vaccinated breeders with a live Salmonella Enteritidis vaccine on day 1 of age was studied by an experimental challenge with Salmonella Enteritidis on day 30 of age. Antibody production of isotypes IgG, IgA and IgM was determined in sera and jejunum of the birds. Vaccination of parent birds resulted in an increase of the antibody concentration in sera and jejunum of the chicks. Own antibody production after administration of the live Salmonella vaccine to the day-old chicks was not detected until day 21 of life. Compared to controls, the number of vaccine organisms in the caeca of the progeny of vaccinated breeder birds was reduced by 0.5-1.5 log10 units. The reduction of the Salmonella Enteritidis vaccine was more pronounced than that of the Salmonella Typhimurium vaccine. However, the reduced colonisation by the live Salmonella vaccine strain did not impair the efficacy of the immunisation of the chicks. To ensure efficacy of the active oral immunisation of chicks from vaccinated parent birds with attenuated live Salmonella vaccines also in case where amounts of maternally transferred antibodies are even higher, it should be guaranteed that chicks take in via drinking water the recommended dose of the vaccine strain. In this connection, factors like the low intake of drinking water by very young chicks, the concentration of the vaccine organisms in the water and the survival of the vaccine should also be considered. 相似文献
19.
Three groups of twelve 35-day-old rabbits were used for the experiment. Two groups were vaccinated with a mixture of precocious lines of Eimeria magna and Eimeria media originating from corresponding wild strains isolated in Benin. One group benefited of a booster whereas the second one was kept without booster. A third non-vaccinated group was used as control. All groups were challenged per os with an equal mixture of the wild strains of E. magna and E. media at a dose of 104 oocysts per animal. Three weeks after the challenge inoculation, no case of diarrhoea was recorded in the two groups of vaccinated rabbits, as compared to the non-vaccinated rabbits that developed diarrhoea. No mortality was recorded in the three groups. During the patent period, oocyst output of vaccinated rabbits was significantly lower than that of control animals (P < 0.01), confirming a good immunogenic characteristic of the precocious lines. No booster effect was noticed for the boost vaccinated group. The daily weigh gain of the two groups of vaccinated rabbits was significantly higher than that of the non-vaccinated rabbits (P < 0.05). Consequently the precocious lines of Benin origin turned out to be immunogenic and therefore constitute good potential candidates for vaccine production for this country. 相似文献
20.
A fusion DNA vaccine co-expressed Eimeria tenella TA4 and chicken IL-2 (chIL-2) was constructed and its efficacy against E. tenella challenge was observed. TA4 gene of E. tenella and chIL-2 gene were cloned into expression vector pcDNA3.1 and pcDNA4.0c in different forms, producing vaccines pcDNA3.1-TA4-IL-2, pcDNA3.1-TA4 and pcDNA4.0c-IL-2. The expression of aim genes in vivo was detected by RT-PCR and western blot. Animal experiment was carried out to evaluate the immune efficacy of the vaccines. Results indicated these DNA vaccines were successfully constructed and the antigen genes could be expressed effectively in vivo. The animal experimental results showed that DNA vaccines could obviously alleviate cecal lesions, body weight loss and increase oocyst decrease ratio. The ACI of pcDNA3.0-TA4-IL-2 group was 192, higher than that of pcDNA3.1-TA4 group. The results suggested that TA4 was an effective candidate antigen for vaccine and co-expression of cytokine with antigen was an alternative method to enhance DNA vaccine immunity. 相似文献